Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NYSE: PEN) | Delayed: 324.96 +1.40 (0.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $323.56 | 52 Week High | $79.49 | |||
| Open | $323.50 | 52 Week Low | $40.23 | |||
| Day High | $325.50 | P/E | N/A | |||
| Day Low | $323.50 | EPS | $0.00 | |||
| Volume | 472,547 | |||||
